The previous lessons covered ways to flatten or soften a keloid without removing it, including injections, silicone, pressure, freezing, and laser treatment. Surgery raises a different possibility: removing the raised tissue. But removing a keloid also creates a fresh wound, and a fresh wound can form another keloid.
This lesson explains why excision alone often fails, why a clinician may pair it with injections or postoperative radiotherapy, and what is gained—and risked—by adding treatment. The central distinction is between removing the existing lump and reducing the chance that the new surgical scar grows into another one.
Why removal does not reset the skin
A keloid results from wound-healing activity that continues beyond what is needed to repair an injury. Fibroblasts produce excess collagen, and scar tissue grows beyond the original wound. Excision removes that tissue, but it does not remove the tendency of the skin at that site to respond this way. Closing the surgical incision starts another round of healing.
The new wound may be larger than the piercing hole or other injury that started the first keloid. Even a neatly closed incision therefore leaves a scar that must heal. This is why recurrence is not simply evidence that a surgeon failed to cut out every bit of the original lump. The problem is also the healing response to the operation itself.
Read the British Association of Dermatologists’ patient guidance for its concise explanation of this trade-off and the main reasons for adding treatment.
The British Association of Dermatologists explains why excision alone is unreliable and introduces treatments used to limit regrowth.
Read “Can a keloid be removed?” from the excision explanation to the end of that section. Then, in “How can a keloid be treated?”, read the treatment overview from its opening paragraph through the radiotherapy bullet. Focus on the difference between improving a scar and curing the tendency to form one.
A review of treatment studies reports recurrence as high as 100% with excision used alone. “As high as” matters: it does not mean every operated keloid returns. It does mean that cutting out a keloid, without a plan for the new wound, is a poor basis for promising permanent removal. Surgery is generally considered for selected keloids—for example, a substantial, troublesome lesion that has not responded adequately to other approaches—rather than as an automatic first step for every raised scar.

Adding injections: treating the new scar as it heals
A clinician can combine excision with intralesional injections—medicine placed into scar tissue or around the surgical site. Corticosteroid injections are one option; a clinician may also consider a regimen involving 5-fluorouracil (5-FU). The aim is not to make the excision more thorough. It is to suppress excessive scar growth during healing and follow-up.
This builds on the earlier lesson about injections. They may flatten tissue and relieve symptoms, but they can require repeated appointments, and a clinician must watch both the scar and the surrounding skin. Steroids can cause thinning or pigment change. Injection regimens can be painful, and some carry risks such as irritation or ulceration. Adding injections therefore changes the expected balance of recurrence risk and treatment burden; it does not make recurrence impossible.
The plan also depends on the wound. A clinician may choose treatment at the operation or during follow-up, rather than expecting you to inject or apply something to a fresh incision yourself. Silicone or a fitted pressure device may sometimes form another part of postoperative care, as covered previously, but silicone belongs on healed skin, not an open surgical wound.
Adding radiotherapy: a different way to limit regrowth
Postoperative radiotherapy directs a controlled course of radiation at the treated area after removal. Its purpose is to reduce the activity of cells that would otherwise build excessive new scar tissue. It is an additional treatment for a confirmed keloid, not a way to evaluate an unexplained piercing bump and not a routine step after every scar removal.
Unlike a course of repeat injections extending over months, postoperative radiotherapy is commonly planned as a short course beginning soon after surgery—often within about a day in published protocols. That timing requires coordination between the surgical and radiation teams before the operation. The review below reports promising results for some combinations, but its studies also differ considerably in treatment schedules, body sites, follow-up, and outcomes. There is no single schedule or result that applies to everyone.
Keloid treatments: an evidence-based systematic review of recent advances
This systematic review brings together evidence on excision followed by radiotherapy and shows why a successful result in one study is not a universal promise.
In “Radiotherapy,” read the opening paragraph, stopping before Table 6. You can skip the table’s individual study rows. Immediately after the table, read the comparison paragraph. Continue into the next paragraph, from timing and uncertainty, then stop. Notice that studies comparing different combinations do not all favor the same approach.
Radiotherapy introduces risks that an injection plan does not. Reported effects include pigment changes and visible small blood vessels; wound-healing problems can occur. Radiation exposure also carries a small potential long-term cancer risk. Its size for an individual depends on the treatment plan and circumstances, so it should be discussed with the treating clinicians rather than dismissed or treated as certain harm. Availability, the site being treated, age, prior treatment, and the feasibility of arranging prompt postoperative care also matter. The British Association of Dermatologists notes that radiotherapy is rarely used in its patient guidance; practice and availability can vary.
Neither addition is automatically “the stronger option.” A particular study may report better results for excision plus injections, while another favors excision plus radiotherapy under different conditions. The systematic review notes that direct comparisons are limited. A clinician must weigh the likely benefit of reducing regrowth against each option’s adverse effects and practical demands.
What a realistic surgical plan promises
For a bothersome earlobe keloid after a piercing, excision may offer an immediate reduction in bulk, but the decision is incomplete without a plan for healing and follow-up. Injections may mean repeat visits and local side effects. Radiotherapy may mean arranging treatment promptly after surgery and accepting radiation-related risks. The right balance is not determined by the keloid’s size alone.
A realistic goal is a flatter, less symptomatic scar with a lower chance of regrowth, not skin that is guaranteed to look as though no injury occurred. Surgery itself leaves an incision scar. If tissue later becomes raised, a clinician may need to assess whether it represents recurrence or another healing problem; a photograph taken soon after treatment cannot settle that question.
The key lesson is that excision removes tissue, while additional treatment aims to influence how the new wound heals. Excision alone has a high recurrence risk; injections or postoperative radiotherapy can lower that risk for selected patients, but each adds burdens and possible harms. The next lesson examines how to interpret reported “success” and recurrence rates without confusing early flattening or symptom relief with permanent removal.